Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Francesco Calvaruso"'
Autor:
Saverio Giampaoli, Nicola La Monica, Daniela Peruzzi, Francesco Calvaruso, Gennaro Ciliberto, Giuseppe Mesiti, Elisa Scarselli, Ekambar R. Kandimalla, Sudhir Agrawal, Carmela Mennuni, Sridhar Dharmapuri, Gaetano Barbato, Luigi Aurisicchio
Publikováno v:
Molecular Therapy. 17:1804-1813
The human telomerase reverse transcriptase (hTERT) is an attractive target for human cancer vaccination because its expression is reactivated in most human tumors. We have evaluated the ability of DNA electroporation (DNA-EP) and adenovirus serotype
Autor:
Carmela Mennuni, Barbara Cipriani, Elisa Peranzoni, Vincenzo Bronte, Francesco Calvaruso, Paola Zanovello, Tania Pannellini, Piero Musiani, Elisa Scarselli, Raffaele De Palma, Stefano Ugel, Lucia Ricci-Vitiani, Manuela Iezzi
Publikováno v:
Blood. 115(7)
Telomerase reverse transcriptase (TERT) is a good candidate for cancer immunotherapy because it is overexpressed in 85% of all human tumors and implicated in maintenance of the transformed phenotype. TERT-based cancer vaccines have been shown to be s
Autor:
Adelaide Friso, Carmela Mennuni, Rosella Tomanin, Francesco Calvaruso, N. La Monica, Alessandra Zanetti, Franco Zacchello, Maurizio Scarpa, Oriano Marin
Publikováno v:
BBA-Molecular Basis of Disease
BBA-Molecular Basis of Disease, Elsevier, 2008, 1782 (10), pp.574. 〈10.1016/j.bbadis.2008.07.001〉
BBA-Molecular Basis of Disease, Elsevier, 2008, 1782 (10), pp.574. 〈10.1016/j.bbadis.2008.07.001〉
Mucopolysaccharidosis type II (MPSII) is an inherited disorder due to a deficiency of the lysosomal enzyme iduronate-2-sulfatase (IDS). The disease is characterized by a considerable deposition of heparan- and dermatan-sulfate, causing a general impa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47e107b21087db27a27977d6ca92f3f3
http://hdl.handle.net/11577/2274843
http://hdl.handle.net/11577/2274843
Autor:
Nicola La Monica, Luigi Aurisicchio, Paolo Monaci, Gennaro Ciliberto, Francesco Calvaruso, Maurizio Nuzzo, Carmela Mennuni, Fabio Palombo, Patrizia Giannetti, Barbara Cipriani
Publikováno v:
International journal of cancer. 120(11)
Scaling up experimental protocols from rodents to humans is often not a straightforward procedure, and this particularly applies to cancer vaccines, where vaccination technology must be especially effective to overcome a variety of immune suppressive
Autor:
Francesco Calvaruso, Fabio Palombo, Leonardo Elia, Valentina Salucci, Alessia Scarito, Mariangela Storto, Carmela Mennuni, Gennaro Ciliberto, Silvia Podda, Nicola La Monica, Luigi Aurisicchio
Publikováno v:
European journal of immunology. 36(5)
The epithelial cell adhesion molecule, Ep-CAM, has been historically considered a target of passive immunotherapy using monoclonal antibodies, and more recently, of a first Pox-vector-based cancer vaccine Phase I trial in colorectal cancer patients.
Autor:
N. La Monica, Valentina Salucci, Francesco Calvaruso, Gennaro Ciliberto, Elisa Scarselli, Carmela Mennuni, R. Cerino, P. Neuner
Publikováno v:
Scandinavian journal of immunology. 63(1)
T-cell tolerance to tumor antigens is a considerable challenge to cancer immunotherapy. The existence of a murine model transgenic for human carcinoembryonic antigen (CEA) allows CEA vaccination efficacy to be studied in a physiologically tolerant co
Autor:
Luigi Aurisicchio, Andrea Facciabene, Carmela Mennuni, Nicola La Monica, Francesco Calvaruso, Gennaro Ciliberto, Mariangela Storto, Elisa Scarselli
Publikováno v:
International journal of cancer. 117(3)
The immunogenic properties of plasmid DNA and recombinant adenovirus (Ad) encoding the carcinoembryonic antigen (CEA) were examined in mice by measuring both the amplitude and type of immune response, and the immunogenicity of codon usage optimized c
Autor:
Immacolata Zampaglione, Elena Fattori, Manuela Cappelletti, Gennaro Ciliberto, Patrizia Costa, Nicola La Monica, Gemma Perretta, Gabriella Rizzuto, Francesco Calvaruso, Carmela Mennuni, Mirko Arcuri
Publikováno v:
The journal of gene medicine 7/2 (2005): 228–236. doi:10.1002/jgm.652
info:cnr-pdr/source/autori:Fattori E.1, Cappelletti M.2, Zampaglione I.3, Mennuni C.4, Calvaruso F.5, Arcuri M.6, Rizzuto G.7, Costa P.8, Perretta G.9, Ciliberto G.10, La Monica N.11/titolo:Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates./doi:10.1002%2Fjgm.652/rivista:The journal of gene medicine/anno:2005/pagina_da:228/pagina_a:236/intervallo_pagine:228–236/volume:7%2F2
info:cnr-pdr/source/autori:Fattori E.1, Cappelletti M.2, Zampaglione I.3, Mennuni C.4, Calvaruso F.5, Arcuri M.6, Rizzuto G.7, Costa P.8, Perretta G.9, Ciliberto G.10, La Monica N.11/titolo:Gene electro-transfer of an improved erythropoietin plasmid in mice and non-human primates./doi:10.1002%2Fjgm.652/rivista:The journal of gene medicine/anno:2005/pagina_da:228/pagina_a:236/intervallo_pagine:228–236/volume:7%2F2
BACKGROUND: Anemia due to impaired erythropoietin (EPO) production is associated with kidney failure. Recombinant proteins are commonly administered to alleviate the symptoms of this dysfunction, whereas gene therapy approaches envisaging the deliver
Autor:
Ernesta Dammassa, Francesco Calvaruso, Gabriella Rizzuto, Gennaro Ciliberto, Elena Fattori, Nicola La Monica, Immacolata Zampaglione, C. Daniela Rinaudo, Carmela Mennuni
Publikováno v:
Human gene therapy. 13(3)
Electrogene transfer (EGT) of plasmid DNA into skeletal muscle is a promising strategy for the treatment of muscle disorders and for the systemic secretion of therapeutic proteins. We report here that preinjecting hyaluronidase (HYAse) significantly
Autor:
Elena Fattori, Luigi Aurisicchio, Immacolata Zampaglione, Mirco Arcuri, Manuela Cappelletti, Barbara Cipriani, Carmela Mennuni, Francesco Calvaruso, Maurizio Nuzzo, Gennaro Ciliberto, Paolo Monaci, Nicola La Monica
Publikováno v:
Human Gene Therapy. :081208041813023